Advertisement

Theoretical Medicine and Bioethics

, Volume 33, Issue 3, pp 163–178 | Cite as

The myth of genetic enhancement

  • Philip M. Rosoff
Article

Abstract

The ongoing revolution in molecular genetics has led many to speculate that one day we will be able to change the expression or phenotype of numerous complex traits to improve ourselves in many different ways. The prospect of genetic enhancements has generated heated controversy, with proponents advocating research and implementation, with caution advised for concerns about justice, and critics tending to see the prospect of genetic enhancements as an assault on human freedom and human nature. Both camps base their arguments on the unquestioned assumption that the science will realize either their dreams or nightmares. In this paper, I show that their beliefs are based upon two fundamental mistakes. First, they are based upon an unwarranted reliance in a genetic determinism that takes for granted that the traits that we might most want to enhance, like intelligence, aggression, shyness, and even athletic ability, can be causally directed by specific genes. In so doing, character descriptions are reified to be concrete and discrete entities, in this case, genes. Second, they have accepted on faith that there is, or will be, a science to translate their hopes or worries into reality when, in fact, that is unlikely to occur because of the irreducible complexity of phenotypic expression.

Keywords

Genetic enhancement Epigenetics Genetic determinism Genetic reification 

Notes

Acknowledgments

I would like to express my gratitude to the Foundation Brocher for affording me the opportunity to have almost 4 weeks of time for reading, thinking, and writing at their facility in Hermance, Switzerland, during which time most of this essay was composed. Without their support, it is unlikely that this essay would have been written in either the form it currently is or the timely manner in which it was completed. I would also like to thank Professors Alex Rosenberg and Dona Chikaraishi for many helpful insights and criticisms. Finally, I would like to express my appreciation to the many authors whose work I have cited for graciously sending me copies of their papers when they were unavailable in my University library system.

References

  1. 1.
    Fukuyama, F. 2002. Our posthuman future: Consequences of the biotechnology revolution. New York: Farrar, Straus & Giroux.Google Scholar
  2. 2.
    Habermas, J. 2003. The future of human nature. Cambridge: Polity.Google Scholar
  3. 3.
    Kass, L.R. 1997. The wisdom of repugnance: Why we should ban the cloning of humans. New Republic 216(22): 17–26.Google Scholar
  4. 4.
    Kass, L.R. 2003. Ageless bodies, happy souls: Biotechnology and the pursuit of perfection. The New Atlantis 1(1): 9–28.Google Scholar
  5. 5.
    Sandel, M.J. 2007. The case against perfection: Ethics in the age of genetic engineering. Cambridge, MA: Belknap Press.Google Scholar
  6. 6.
    Harris, J. 2007. Enhancing evolution: The ethical case for making better people. Princeton: Princeton University Press.Google Scholar
  7. 7.
    Savulescu, J. 2001. Procreative beneficence: Why we should select the best children. Bioethics 15(5–6): 413–426.CrossRefGoogle Scholar
  8. 8.
    Savulescu, J. 2005. New breeds of humans: The moral obligation to enhance. Reproductive Biomedicine Online 10(suppl. 1): 36–39.CrossRefGoogle Scholar
  9. 9.
    Savulescu, J., and G. Kahane. 2009. The moral obligation to create children with the best chance of the best life. Bioethics 23(5): 274–290.CrossRefGoogle Scholar
  10. 10.
    Buchanan, A. 2008. Enhancement and the ethics of development. Kennedy Institute of Ethics Journal 18(1): 1–34.CrossRefGoogle Scholar
  11. 11.
    Buchanan, A., D.W. Brock, N. Daniels, and D. Wikler. 2000. From chance to choice: Genetics and justice. New York: Cambridge University Press.Google Scholar
  12. 12.
    Shickle, D. 2000. Are “genetic enhancements” really enhancements? Cambridge Quarterly of Healthcare Ethics 9(3): 342–352.CrossRefGoogle Scholar
  13. 13.
    Savulescu, J. 2006. Justice, fairness, and enhancement. Annals of the New York Academy of Sciences 1093: 321–338.CrossRefGoogle Scholar
  14. 14.
    Holtug, N. 1999. Does justice require genetic enhancements? Journal of Medical Ethics 25(2): 137–143.CrossRefGoogle Scholar
  15. 15.
    Boorse, C. 1975. On the distinction between disease and illness. Philosophy & Public Affairs 5(1): 49–68.Google Scholar
  16. 16.
    Boorse, C. 1977. Health as a theoretical concept. Philosophy of Science 44(4): 542–573.CrossRefGoogle Scholar
  17. 17.
    Hyman, D.A. 1990. Aesthetics and ethics: The implications of cosmetic surgery. Perspectives in Biology and Medicine 33(2): 190–202.Google Scholar
  18. 18.
    Bertolaso, M., J. Olsson, A. Picardi, and J. Rakela. 2010. Gene therapy and enhancement for diabetes (and other diseases): The multiplicity of considerations. Diabetes/Metabolism Research and Reviews 26(7): 520–524.CrossRefGoogle Scholar
  19. 19.
    Sparrow, R. 2010. Better than men? Sex and the therapy/enhancement distinction. Kennedy Institute of Ethics Journal 20(2): 115–144.CrossRefGoogle Scholar
  20. 20.
    Giacca, M. 2010. Ethical and social problems of gene therapy. In Gene therapy, 283–292. Milan: Springer.Google Scholar
  21. 21.
    Lewontin, R.C. 1976. Race and intelligence. In The IQ controversy: A critical reader, ed. N.J. Block and G. Dworkin, 78–92. New York: Pantheon.Google Scholar
  22. 22.
    Gould, S.J. 1981. The mismeasure of man, 2nd ed. New York: W.W. Norton.Google Scholar
  23. 23.
    Kelley, T.L. 1927. Interpretation of educational measurements. Yonkers-on-Hudson: World Book Company.Google Scholar
  24. 24.
    Duster, T. 2005. Enhanced: Race and reification in science. Science 307(5712): 1050–1051.CrossRefGoogle Scholar
  25. 25.
    Nathwani, A.C., E.G.D. Tuddenham, S. Rangarajan, et al. 2011. Adenovirus-associated virus vector: Mediated gene transfer in hemophilia B. New England Journal of Medicine 365(25): 2357–2365.CrossRefGoogle Scholar
  26. 26.
    Spearman, C. 1914. The measurement of intelligence. Eugenics. Review 6(4): 312–313.Google Scholar
  27. 27.
    Gardner, H. 2006. Multiple intelligences: New horizons in theory and practice, 2nd ed. New York: Basic Books.Google Scholar
  28. 28.
    Lewontin, R.C. 1976. Sociobiology: A caricature of Darwinism. PSA: Proceedings of the Biennial Meeting of the Philosophy of Science Association 2: 22–31.Google Scholar
  29. 29.
    Rosoff, P.M. 2010. In search of the mommy gene: Truth and consequences in behavioral genetics. Science, Technology and Human Values 35(2): 200–243.CrossRefGoogle Scholar
  30. 30.
    Rosoff, P.M. 2011. I’ll be a monkey’s uncle: A moral challenge to human genetic enhancement research. Journal of Medical Ethics 37: 611–615.CrossRefGoogle Scholar
  31. 31.
    Baker, L.A., C. Tuvblad, C. Reynolds, M. Zheng, D.I. Lozano, and A. Raine. 2009. Resting heart rate and the development of antisocial behavior from age 9 to 14: Genetic and environmental influences. Development and Psychopathology 21(3): 939–960.CrossRefGoogle Scholar
  32. 32.
    Chen, C., D.G. Rainnie, R.W. Greene, and S. Tonegawa. 1994. Abnormal fear response and aggressive behavior in mutant mice deficient for alpha-calcium-calmodulin kinase II. Science 266(5183): 291–294.CrossRefGoogle Scholar
  33. 33.
    Seattle Post Intelligencer. 2005. Remove fear gene and you get Mighty Mouse. November 18.Google Scholar
  34. 34.
    Hayden, E.P., L.R. Dougherty, B. Maloney, et al. 2007. Temperamental fearfulness in childhood and the serotonin transporter promoter region polymorphism: A multimethod association study. Psychiatric Genetics 17(3): 135–142.CrossRefGoogle Scholar
  35. 35.
    Shumyatsky, G.P., G. Malleret, R.M. Shin, et al. 2005. Stathmin, a gene enriched in the amygdala, controls both learned and innate fear. Cell 123(4): 697–709.CrossRefGoogle Scholar
  36. 36.
    Alper, J.S. 1998. Genes, free will, and criminal responsibility. Social Science and Medicine 46(12): 1599–1611.CrossRefGoogle Scholar
  37. 37.
    DeLisi, M., K.M. Beaver, J.P. Wright, and M.G. Vaughn. 2008. The etiology of criminal onset: The enduring salience of nature and nurture. Journal of Criminal Justice 36(3): 217–223.CrossRefGoogle Scholar
  38. 38.
    Rajender, S., G. Pandu, J.D. Sharma, K.P. Gandhi, L. Singh, and K. Thangaraj. 2008. Reduced CAG repeats length in androgen receptor gene is associated with violent criminal behavior. International Journal of Legal Medicine 122(5): 367–372.CrossRefGoogle Scholar
  39. 39.
    Vaughn, M.G., M. DeLisi, K.M. Beaver, and J.P. Wright. 2009. DAT1 and 5HTT are associated with pathological criminal behavior in a nationally representative sample of youth. Criminal Justice and Behavior 36(11): 1113–1124.CrossRefGoogle Scholar
  40. 40.
    Tang, Y.P., E. Shimizu, G.R. Dube, C. Rampon, G.A. Kerchner, M. Zhuo, G. Liu, and J.Z. Tsien. 1999. Genetic enhancement of learning and memory in mice. Nature 401(6748): 63–69.CrossRefGoogle Scholar
  41. 41.
    Qu, X.X., J. Cai, M.J. Li, et al. 2009. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain. Experimental Neurology 215(2): 298–307.CrossRefGoogle Scholar
  42. 42.
    Malinow, R. 2011. New developments on the role of NMDA receptors in Alzheimer’s disease. Current Opinion in Neurobiology. doi: 10.1016/j.conb.2011.09.001.Google Scholar
  43. 43.
    Trut, L.N. 1999. Early canid domestication: The farm-fox experiment. American Scientist 87(2): 160.Google Scholar
  44. 44.
    Wright, S. 1920. The relative importance of heredity and environment in determining the piebald pattern of guinea pigs. Proceedings National Academy of Sciences USA 6: 320–332.CrossRefGoogle Scholar
  45. 45.
    Gartner, K., and E. Baunack. 1981. Is the similarity of monozygotic twins due to genetic factors alone? Nature 292(5824): 646–647.CrossRefGoogle Scholar
  46. 46.
    Gartner, Klaus. 1990. A third component causing random variability beside environment and genotype: A reason for the limited success of a 30 year long effort to standardize laboratory animals? Laboratory Animals 24(1): 71–77.CrossRefGoogle Scholar
  47. 47.
    Waddington, C.H. 1942. The epigenotype. Endeavor 1: 18–20.Google Scholar
  48. 48.
    Molenaar, P.C., D.I. Boomsma, and C.V. Dolan. 1993. A third source of developmental differences. Behavior Genetics 23(6): 519–524.CrossRefGoogle Scholar
  49. 49.
    Peaston, A.E., and E. Whitelaw. 2006. Epigenetics and phenotypic variation in mammals. Mammalian Genome 17(5): 365–374.CrossRefGoogle Scholar
  50. 50.
    Healey, S.C., K.M. Kirk, V.J. Hyland, et al. 2001. Height discordance in monozygotic females is not attributable to discordant inactivation of X-linked stature determining genes. Twin Research 4(1): 19–24.Google Scholar
  51. 51.
    Javierre, B.M., A.F. Fernandez, J. Richter, et al. 2010. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Research 20(2): 170–179.CrossRefGoogle Scholar
  52. 52.
    Petronis, A. 2004. The origin of schizophrenia: Genetic thesis, epigenetic antithesis, and resolving synthesis. Biological Psychiatry 55(10): 965–970.CrossRefGoogle Scholar
  53. 53.
    Singh, S.M., and R. O’Reilly. 2009. (Epi)genomics and neurodevelopment in schizophrenia: Monozygotic twins discordant for schizophrenia augment the search for disease-related (epi)genomic alterations. Genome 52(1): 8–19.CrossRefGoogle Scholar
  54. 54.
    Fraga, M.F., E. Ballestar, M.F. Paz, et al. 2005. Epigenetic differences arise during the lifetime of monozygotic twins. Proceedings of the National Academy of Sciences USA 102(30): 10604–10609.CrossRefGoogle Scholar
  55. 55.
    Wong, A.H.C., I.I. Gottesman, and A. Petronis. 2005. Phenotypic differences in genetically identical organisms: The epigenetic perspective. Human Molecular Genetics 14(suppl. 1): R11–R18.CrossRefGoogle Scholar
  56. 56.
    Petronis, A. 2006. Epigenetics and twins: Three variations on the theme. Trends in Genetics 22(7): 347–350.CrossRefGoogle Scholar
  57. 57.
    Kaminsky, Z.A., T. Tang, S.C. Wang, et al. 2009. DNA methylation profiles in monozygotic and dizygotic twins. Nature Genetics 41(2): 240–245.CrossRefGoogle Scholar
  58. 58.
    Ollikainen, M., K.R. Smith, E.J. Joo, et al. 2010. DNA methylation analysis of multiple tissues from newborn twins reveals both genetic and intrauterine components to variation in the human neonatal epigenome. Human Molecular Genetics 19(21): 4176–4188.CrossRefGoogle Scholar
  59. 59.
    Maunakea, A.K., I. Chepelev, K. Zhao, and B. Bruneau. 2010. Epigenome mapping in normal and disease states. Circulation Research 107(3): 327–339.CrossRefGoogle Scholar
  60. 60.
    Townsend, G.C., L. Richards, T. Hughes, S. Pinkerton, and W. Schwerdt. 2005. Epigenetic influences may explain dental differences in monozygotic twin pairs. Australian Dental Journal 50(2): 95–100.CrossRefGoogle Scholar
  61. 61.
    Manning, J.T., B. Fink, N. Neave, and A. Szwed. 2006. The second to fourth digit ratio and asymmetry. Annals of Human Biology 33(4): 480–492.CrossRefGoogle Scholar
  62. 62.
    Sherman, A. 2011. Dynamical systems theory in physiology. Journal of General Physiology 138(1): 13–19.CrossRefGoogle Scholar
  63. 63.
    Kan, K.J., A. Ploeger, M.E.J. Raijmakers, C.V. Dolan, and H.L.J. Van Der Maas. 2010. Nonlinear epigenetic variance: Review and simulations. Developmental Science 13(1): 11–27.CrossRefGoogle Scholar
  64. 64.
    Turner, B.M. 2009. Epigenetic responses to environmental change and their evolutionary implications. Philosophical Transactions of the Royal Society of London. Series B, Biological sciences 364(1534): 3403–3418.CrossRefGoogle Scholar
  65. 65.
    Champagne, F.A., and J.P. Curley. 2009. Epigenetic mechanisms mediating the long-term effects of maternal care on development. Neuroscience and Biobehavioral Reviews 33(4): 593–600.CrossRefGoogle Scholar
  66. 66.
    Weaver, I.C.G. 2009. Life at the interface between a dynamic environment and a fixed genome: Epigenetic programming of stress responses by maternal behavior. In Mammalian Brain Development, ed. D. Janigro. New York: Humana Press.Google Scholar
  67. 67.
    Anway, M.D., A.S. Cupp, M. Uzumcu, and M.K. Skinner. 2005. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308(5727): 1466–1469.CrossRefGoogle Scholar
  68. 68.
    Newbold, R.R. 2008. Prenatal exposure to diethylstilbestrol (DES). Fertility and Sterility 89(suppl. 2): e55–e56.CrossRefGoogle Scholar
  69. 69.
    Katari, S., N. Turan, M. Bibikova, et al. 2009. DNA methylation and gene expression differences in children conceived in vitro or in vivo. Human Molecular Genetics 18(20): 3769–3778.CrossRefGoogle Scholar
  70. 70.
    Scaffidi, P., and T. Misteli. 2010. Cancer epigenetics: From disruption of differentiation programs to the emergence of cancer stem cells. Cold Spring Harbor Symposia on Quantitative Biology 75: 1–8.CrossRefGoogle Scholar
  71. 71.
    Shannon, K., and S.A. Armstrong. 2010. Genetics, epigenetics, and leukemia. New England Journal of Medicine 363(25): 2460–2461.CrossRefGoogle Scholar
  72. 72.
    Swami, M. 2010. Epigenetics: Demethylation links cell fate and cancer. Nature Reviews Cancer 10(11): 740.CrossRefGoogle Scholar
  73. 73.
    Goldstein, D.B. 2009. Common genetic variation and human traits. New England Journal of Medicine 360(17): 1696–1698.CrossRefGoogle Scholar
  74. 74.
    Manolio, T.A. 2010. Genomewide association studies and assessment of the risk of disease. New England Journal of Medicine 363(2): 166–176.CrossRefGoogle Scholar
  75. 75.
    Manolio, T.A., F.S. Collins, N.J. Cox, et al. 2009. Finding the missing heritability of complex diseases. Nature 461(7265): 747–753.CrossRefGoogle Scholar
  76. 76.
    Brown, J.R., H. Ye, R.T. Bronson, P. Dikkes, and M.E. Greenberg. 1996. A defect in nurturing in mice lacking the immediate early gene fosB. Cell 86(2): 297–309.CrossRefGoogle Scholar
  77. 77.
    Kurnit, D.M., W.M. Layton, and S. Matthysse. 1987. Genetics, chance, and morphogenesis. American Journal of Human Genetics 41(6): 979–995.Google Scholar
  78. 78.
    Eichler, E.E., J. Flint, G. Gibson, A. Kong, S.M. Leal, J.H. Moore, and J.H. Nadeau. 2010. Missing heritability and strategies for finding the underlying causes of complex disease. Nature Reviews Genetics 11(6): 446–450.CrossRefGoogle Scholar
  79. 79.
    Nijhout, H.F. 2003. On the association between genes and complex traits. Journal of Investigative Dermatology 8(2): 162–163.CrossRefGoogle Scholar
  80. 80.
    Tschirren, B., and S. Bensch. 2010. Genetics of personalities: No simple answers for complex traits. Molecular Ecology 19(4): 624–626.CrossRefGoogle Scholar
  81. 81.
    Rothstein, M.A., Y. Cai, and G.E. Marchant. 2009. The ghost in our genes: Legal and ethical implications of epigenetics. Health Matrix Cleveland 19(1): 1–62.Google Scholar
  82. 82.
    Powell, R. 2010. What’s the harm? An evolutionary theoretical critique of the precautionary principle. Kennedy Institute of Ethics Journal 20(2): 181–206.CrossRefGoogle Scholar
  83. 83.
    Rosoff, P.M., and A. Rosenberg. 2006. How Darwinian reductionism refutes genetic determinism. Studies in History and Philosophy of Biological and Biomedical Sciences 37(1): 122–135.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  1. 1.Departments of Pediatrics and Medicine and Trent Center for Bioethics, Humanities, and History of MedicineDuke University Medical CenterDurhamUSA

Personalised recommendations